My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 101

    1.

    Mitogen Activated Protein kinase signal transduction pathways in the prostate.

    Maroni PD, Koul S, Meacham RB, Koul HK.

    Cell Commun Signal. 2004 Jun 25;2(1):5.PMID: 15219238 [PubMed - as supplied by publisher]Related articlesFree article

    2.

    Melatonin induces apoptotic death in LNCaP cells via p38 and JNK pathways: therapeutic implications for prostate cancer.

    Joo SS, Yoo YM.

    J Pineal Res. 2009 Aug;47(1):8-14. Epub 2009 Jun 10.PMID: 19522739 [PubMed - indexed for MEDLINE]Related articles

    3.

    [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment]

    Zhang YX, Kong CZ.

    Zhonghua Yi Xue Za Zhi. 2008 Jan 22;88(4):271-5. Chinese. PMID: 18361842 [PubMed - indexed for MEDLINE]Related articles

    4.

    Opposing roles of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinase in the cellular response to ionizing radiation in human cervical cancer cells.

    Kim MJ, Choi SY, Park IC, Hwang SG, Kim C, Choi YH, Kim H, Lee KH, Lee SJ.

    Mol Cancer Res. 2008 Nov;6(11):1718-31.PMID: 19010820 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.

    Ou YC, Yang CR, Cheng CL, Raung SL, Hung YY, Chen CJ.

    Eur J Pharmacol. 2007 Jun 1;563(1-3):49-60. Epub 2007 Feb 8.PMID: 17341418 [PubMed - indexed for MEDLINE]Related articles

    8.

    ERK and JNK signaling pathways are involved in the regulation of activator protein 1 and cell death elicited by three isothiocyanates in human prostate cancer PC-3 cells.

    Xu C, Shen G, Yuan X, Kim JH, Gopalkrishnan A, Keum YS, Nair S, Kong AN.

    Carcinogenesis. 2006 Mar;27(3):437-45. Epub 2005 Nov 4.PMID: 16272172 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.

    McCubrey JA, Steelman LS, Abrams SL, Lee JT, Chang F, Bertrand FE, Navolanic PM, Terrian DM, Franklin RA, D'Assoro AB, Salisbury JL, Mazzarino MC, Stivala F, Libra M.

    Adv Enzyme Regul. 2006;46:249-79. Epub 2006 Jul 18.PMID: 16854453 [PubMed - indexed for MEDLINE]Related articles

    11.

    Development and implementation of three mitogen-activated protein kinase (MAPK) signaling pathway imaging assays to provide MAPK module selectivity profiling for kinase inhibitors: MK2-EGFP translocation, c-Jun, and ERK activation.

    Nickischer D, Laethem C, Trask OJ Jr, Williams RG, Kandasamy R, Johnston PA, Johnston PA.

    Methods Enzymol. 2006;414:389-418.PMID: 17110204 [PubMed - indexed for MEDLINE]Related articles

    12.

    Activation of c-jun N-terminal kinase is associated with cell proliferation and shorter relapse-free period in superficial spreading malignant melanoma.

    Jørgensen K, Davidson B, Flørenes VA.

    Mod Pathol. 2006 Nov;19(11):1446-55. Epub 2006 Sep 1.PMID: 16951673 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic airways.

    Liu W, Liang Q, Balzar S, Wenzel S, Gorska M, Alam R.

    J Allergy Clin Immunol. 2008 Apr;121(4):893-902.e2.PMID: 18395552 [PubMed - indexed for MEDLINE]Related articles

    14.

    Critical role of the c-JunNH2-terminal kinase and p38 mitogen-activated protein kinase pathways on sodium butyrate-induced apoptosis in DU145 human prostate cancer cells.

    Cho SD, Ahn NS, Jung JW, Yang SR, Park JS, Lee YS, Jo EH, Hwang JW, Lii J, Kang KS.

    Eur J Cancer Prev. 2006 Feb;15(1):57-63.PMID: 16374231 [PubMed - indexed for MEDLINE]Related articles

    16.

    Reactivation of Kaposi's sarcoma-associated herpesvirus from latency requires MEK/ERK, JNK and p38 multiple mitogen-activated protein kinase pathways.

    Xie J, Ajibade AO, Ye F, Kuhne K, Gao SJ.

    Virology. 2008 Feb 5;371(1):139-54. Epub 2007 Oct 26.PMID: 17964626 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    SB203580, a pharmacological inhibitor of p38 MAP kinase transduction pathway activates ERK and JNK MAP kinases in primary cultures of human hepatocytes.

    Henklova P, Vrzal R, Papouskova B, Bednar P, Jancova P, Anzenbacherova E, Ulrichova J, Maurel P, Pavek P, Dvorak Z.

    Eur J Pharmacol. 2008 Sep 28;593(1-3):16-23. Epub 2008 Jul 10.PMID: 18655782 [PubMed - indexed for MEDLINE]Related articles

    18.

    Coordinate signaling by Src and p38 kinases in the induction of cortical cataracts.

    Zhou J, Menko AS.

    Invest Ophthalmol Vis Sci. 2004 Jul;45(7):2314-23.PMID: 15223811 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Carprofen induction of p75NTR-dependent apoptosis via the p38 mitogen-activated protein kinase pathway in prostate cancer cells.

    Khwaja FS, Quann EJ, Pattabiraman N, Wynne S, Djakiew D.

    Mol Cancer Ther. 2008 Nov;7(11):3539-45. Epub 2008 Oct 30.PMID: 18974393 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.

    Unni E, Sun S, Nan B, McPhaul MJ, Cheskis B, Mancini MA, Marcelli M.

    Cancer Res. 2004 Oct 1;64(19):7156-68.PMID: 15466214 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk